Correlation Between Nice and Teva Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Nice and Teva Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nice and Teva Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nice and Teva Pharmaceutical Industries, you can compare the effects of market volatilities on Nice and Teva Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nice with a short position of Teva Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nice and Teva Pharmaceutical.

Diversification Opportunities for Nice and Teva Pharmaceutical

-0.64

Correlation Coefficient

Nice  Teva Pharmaceutical

Excellent diversification

The 3 months correlation between Nice and Teva is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Nice and Teva Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharmaceutical and Nice is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nice are associated (or correlated) with Teva Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharmaceutical has no effect on the direction of Nice i.e., Nice and Teva Pharmaceutical go up and down completely randomly.

Pair Corralation between Nice and Teva Pharmaceutical

Assuming the 90 days trading horizon Nice is expected to under-perform the Teva Pharmaceutical. In addition to that, Nice is 2.46 times more volatile than Teva Pharmaceutical Industries. It trades about -0.54 of its total potential returns per unit of risk. Teva Pharmaceutical Industries is currently generating about 0.05 per unit of volatility. If you would invest  624,400  in Teva Pharmaceutical Industries on March 11, 2024 and sell it today you would earn a total of  5,400  from holding Teva Pharmaceutical Industries or generate 0.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Nice  vs.  Teva Pharmaceutical Industries

Nice

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nice has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in July 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Teva Pharmaceutical

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharmaceutical Industries are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Teva Pharmaceutical sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Nice and Teva Pharmaceutical

The main advantage of trading using opposite Nice and Teva Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nice position performs unexpectedly, Teva Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharmaceutical will offset losses from the drop in Teva Pharmaceutical's long position.

The idea behind Nice and Teva Pharmaceutical Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.